ISSN 0973 - 9289

August 2017 NEWSLETTER

HIV IN CHILDREN
August 2017 Newsletter
FACEBOOK TWITTER YOUTUBE
GRAND ROUNDS
A 9 years old boy was detected to be HIV infected in 2008. He was started on antiretroviral therapy (ART) consisting of stavudine (d4T), lamivudine (3TC) and nevirapine (NVP). He was alright till February 2013 when he was detected to have MDR pulmonary TB. CD4 count was 254 cells/cumm and HIV viral load was was 23,000 copies/ml. ART was shifted to tenofovir (TDF), emtricitabine and atazanavir-ritonavir. Anti-tuberculous therapy consisted of ethambutol, ofloxacin, PAS, Ethionamide, Cycloserine and kanamycin. On follow up after 2 months, HIV viral load was 87 copies/ml.

Are there any drug interactions between ART and second line ATT?

>> Read More...
Question Of the Day
Q. What are the signs in children on HIV?
>> Answer Now...
 
>> HIV BLOGS >> ASK EXPERTS
 
SUBMIT TO HIV IN CHILDREN
HIV IN CHILDREN ensures that your scientific research gets the maximum coverage and visibility both internationally and nationally that it deserves. SUBMIT TO HIV IN CHILDREN - HAVE A GLOBAL PRESENCE

>> Submit Now
HIV ARTICLE
>> PROPHYLAXIS FOR CYTOMEGALOVIRUS INFECTION (CMV)
PARTNER SITES
>> Pediatric Oncall >> Medical Adris
>> Vaccine Reminder  
Hiv in Children

This website is with a purpose to create awareness about impact of HIV in children, to dispel the myths and misconceptions and to aid the clinicians to develop a clinical acumen for effective management of these children and the affected families.




Contact

HIV IN CHILDREN,

1/B,Saguna,271/B,

St.Francis Road

Vile Parle(W),

Mumbai-400056.

E-Mail Address : info@hivinchildren.org


Copyright © 2001 - 2024 HIV In Children All Rights Reserved. All trademarks used are the properties of their respective owners.
Disclaimer: The information given by www.hivinchildren.org is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by HivInChildren of the quality or value of the said product or of claims made by its manufacturer.